医療従事者の為の最新医療ニュースや様々な情報・ツールを提供する医療総合サイト

GN ReSound Opens Johor Malaysia Factory and Distribution Center to Support Continued Company Growth

2015年09月03日 PM03:00
このエントリーをはてなブックマークに追加


 

COPENHAGEN, Denmark

Today, GN ReSound®, a global leader in innovative hearing technologies, hosted an official opening ceremony for the company’s newest manufacturing and distribution facility in Kulaijaya, Johor, Malaysia. The new 5,000 m2 facility expands GN ReSound’s global production capacity and will also serve as a new distribution hub for the region.

This Smart News Release features multimedia. View the full release here: http://www.businesswire.com/news/home/20150902005935/en/

GN ReSound's new 5,000 square meters manufacturing and distribution facility in Kulaijaya, Johor, Ma ...

GN ReSound’s new 5,000 square meters manufacturing and distribution facility in Kulaijaya, Johor, Malaysia expands GN ReSound’s global production capacity and will also serve as a new distribution hub for the region. (Photo: Business Wire)

GN ReSound Chief Executive Officer Mr. Anders Hedegaard hosted the event and was joined by Malaysian and Danish dignitaries including Danish Ambassador to Malaysia H.E. Mr. Nicolai Ruge and Yang Berhormat Dato’ Sri Mustapa Mohamed, Malaysia’s Minister of International Trade and Industry, in addition to a number of GN ReSound global executives and newly-hired employees. The launch event also included a facility tour, product demonstrations, and a press conference for members of the media.

“GN ReSound’s expansion into Malaysia represents the latest effort in our ongoing commitment to meeting the growing global demand for innovative hearing solutions,” said Mr. Hedegaard. “This first-class facility will advance our mission and help us continue to revolutionize what is possible in terms of hearing accessibility.”

GN ReSound’s Johor, Malaysia location was selected after a thorough evaluation of more than a dozen locations around the world. The facility’s daily operations will benefit from its proximity to Singapore’s logistics infrastructure and excellent vendor and support relationships with a number of local area businesses. More than one hundred employees have been hired to-date. The facility has the potential to support approximately 450 total jobs at full capacity.

The company also maintains manufacturing and distribution facilities in Xiamen, China, the UK, Spain, and R&D and manufacturing facilities in Denmark and the United States.

In early 2015, GN ReSound launched their newest Smart Hearing aid; ReSound LiNX2™ is a full family of models with improvements in spatial hearing, tinnitus management and, for the first time ever, direct streaming from Apple devices to custom molded products. As well, it allows users to personalize their hearing experience via the award-winning ReSound Smart™ app.

ReSound’s revolutionary hearing aid technology is available through a global network of hearing care professionals. Consumers can find more information about ReSound’s portfolio of Smart Hearing aids on www.resound.com.

About GN ReSound

GN ReSound is a leading international developer and manufacturer of advanced and innovative hearing healthcare solutions. The company offers a full range of hearing aids, accessories and diagnostic instruments under the ReSound, Beltone, Interton, and Otometrics brand names. GN ReSound’s revolutionary wireless technology allows wearers to personalize their hearing like never before. With its unique sound processing designed to mimic the natural ear, GN ReSound is making life sound better.

View source version on businesswire.com: http://www.businesswire.com/news/home/20150902005935/en/

CONTACT

GN ReSound
John Procter, +1-703-587-9967
jprocter@mcbeestrategic.com
or
Savannah
Bailey, +1-561-827-4510
sbailey@mcbeestrategic.com

Related Posts Plugin for WordPress, Blogger...
 

同じカテゴリーの記事 

  • 武田和Seattle Genetics呈报3期ECHELON-1临床试验的阳性数据,该试验评估ADCETRIS® (brentuximab vedotin)用于晚期霍奇金淋巴瘤的一线治疗
  • ADCセラピューティクスが当社の新規抗体薬物複合体ADCT-301の第I相中間データを発表
  • Intercell USA Changes Name to Valneva USA, Inc. and Expands Commercial Presence
  • ADC Therapeutics präsentiert Zwischenergebnisse aus Phase-I-Studie zu neuartigem Antikörper-Wirkstoff-Konjugat ADCT-402
  • Bertin与Zymo Research宣布达成新的合作